You are here
The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.
SBC: AGAVE BIOSYSTEMS INC. Topic: N/A
The preponderance of biosensors under development today rely on labeling reagents such as fluorescent, radioisotopic or enzymatic tags. As a result, the added complexity of these reagents and their incorporation into the detection system has resulted in designs that are difficult to implement or that require significant sample preparation steps before introduction into the detection instrument. ...SBIR Phase I 1998 Department of DefenseOffice for Chemical and Biological Defense
SBC: Invitro Diagnostics, Inc. Topic: N/A
Current geopolitical strategies require effective warfare countermeasures to protect U.S. forces against biological and chemical threats. Today's molecular biology and immunological detection technologies cannot be used to produce automated biodetectors useable in the battlefield. New, improved detection technologies are needed to minimize the impact of chemical and biological weapons on Army per ...SBIR Phase I 1998 Department of DefenseOffice for Chemical and Biological Defense
SBC: AGAVE BIOSYSTEMS INC. Topic: CBD10108
Organophosphorus chemical warfare nerve agents (OP-CWA) are attractive to terrorist groups and rogue states as an inexpensive and accessible technology for chemical warfare. OP-CWA and organophosphate pesticides cause severe neurological symptoms and death by inhibiting the enzyme acetylcholinesterase (AChE); the resulting excess acetylcholine accumulates and overstimulates the human or animal bo ...SBIR Phase I 2010 Department of DefenseOffice for Chemical and Biological Defense